Skip to main content

and
  1. Article

    Open Access

    Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial

    Gene expression (GEX) signatures in breast cancer provide prognostic information, but little is known about their predictive value for tamoxifen treatment. We examined the tamoxifen-predictive value and progno...

    Christine Lundgren, Julia Tutzauer, Sarah E. Church, Olle Stål in Breast Cancer Research (2023)

  2. Article

    Open Access

    PAM50 subty** and ROR score add long-term prognostic information in premenopausal breast cancer patients

    PAM50 intrinsic subty** and risk of recurrence (ROR) score are approved for risk profiling in postmenopausal women. We aimed to examine their long-term prognostic value in terms of breast cancer-free interva...

    Christine Lundgren, Pär-Ola Bendahl, Sarah E. Church, Maria Ekholm in npj Breast Cancer (2022)

  3. Article

    Open Access

    Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up

    Tumour-infiltrating lymphocytes (TILs) are of important prognostic and predictive value in human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) and triple-negative breast cancer (TNBC),...

    Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö in Breast Cancer Research (2020)

  4. Article

    Open Access

    Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

    The study aimed to investigate expression of epithelial-to-mesenchymal transition (EMT)-related proteins and phenotypes during breast cancer progression and to relate this to patient outcome.

    Charlotte Levin Tykjær Jørgensen, Carina Forsare in Breast Cancer Research and Treatment (2020)

  5. Article

    Open Access

    Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

    The rapid development of new therapies in metastatic breast cancer (MBC), entails a need for improved prognostic and monitoring tools. Thymidine kinase 1 (TK1) is involved in DNA synthesis and its activity cor...

    Anna-Maria Larsson, Pär-Ola Bendahl, Kristina Aaltonen, Sara Jansson in Scientific Reports (2020)

  6. Article

    Open Access

    The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast

    According to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, progesterone receptor (PR) and Nottingham histological grade (NHG) are used for prognostic classification of estrogen rece...

    Ulrik Narbe, Martin Sjöström, Carina Forsare in Breast Cancer Research and Treatment (2019)

  7. Article

    Open Access

    Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

    Prognostic factors in breast cancer are often measured on a continuous scale, but categorized for clinical decision-making. The primary aim of this study was to evaluate if accounting for continuous non-linear...

    Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau in BMC Cancer (2018)